Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-04

Clinical Trial Update: Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events [Phase 4]

View source ↗

Summary

A Phase 4 trial compares cilostazol to aspirin for primary prevention of atherosclerotic events in adults with Type 2 Diabetes Mellitus. The study status is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Cilostazol (Cilostazol)

Snippet

Sponsor: Hanyang University | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: UNKNOWN